A randomized controlled trial of Solcoseryl and DuoDerm in chronic sickle-cell ulcers
West Indian med. j
;
42(3): 121-3, Sept. 1993.
Artículo
en Inglés
| LILACS
| ID: lil-130582
ABSTRACT
A randomized controlled trial of Solcoseryl, DuoDerm and conventional conservative therapy with Eusol has been performed in 32 patients with homozygous sickle-cell (SS) disease. After 12 weeks' baseline observation, patients were randomized to one of three therapies and monitored for a further 12 weeks. Of 44 ulcerated legs, 20 received control treatment, 12 Solcoseryl and 12 DuoDerm. DuoDerm was generally unacceptable, and two-thirds of the patients defaulted from this treatment. Solcoseryl increased ulcer healing compared to the controls but the difference was not significant. Solcoseryl was well tolerated and may have a role in the treatment of chronic leg ulcers of sickle-cell disease.
Buscar en Google
Índice:
LILACS (Américas)
Asunto principal:
Actiemil
/
Coloides
/
Anemia de Células Falciformes
/
Úlcera de la Pierna
/
Apósitos Oclusivos
Tipo de estudio:
Ensayo Clínico Controlado
Límite:
Femenino
/
Humanos
/
Masculino
País/Región como asunto:
Caribe Inglés
/
Jamaica
Idioma:
Inglés
Revista:
West Indian med. j
Asunto de la revista:
Medicina
Año:
1993
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS